No salesforce purge in Pfizer’s $4 billion cuts
April 7, 2005Sales and Marketing
Pfizer has set out a $4 billion cost cutting programme for the next three years in an attempt to return …
New hepatitis B treatment approved in US
April 6, 2005Sales and Marketing
Bristol-Myers Squibb has received US approval for its hepatitis B treatment Baraclude after a six-month priority review.Baraclude (entecavir) is BMS's …
Takeda abandons phase III diabetes drug
April 5, 2005Research and Development
Takeda has been forced to abandon one of its lead pipeline products after a small number of patients in clinical …
Interactive sampling
April 4, 2005Sales and Marketing
The internet has changed the way many of us live our lives, from grocery shopping to booking holidays, but can …
Government fails to meet GP recruitment target
March 31, 2005The government has fallen short of recruiting its target number of new family doctors, despite figures showing an increase in …
Super surgeries spell big changes for patients and pharma
March 31, 2005GPs will be given the freedom to carry out services traditionally only available in hospitals as the government unveiled plans …
And finally – the NSF for Long Term Conditions
March 31, 2005The National Service Framework for Long Term Conditions has been launched by the government, which has pledged that it will …
Renamed agency responds to pharma’s strategic aims
March 31, 2005Medical Communications
Healthcare communications agency Brader Perryman has changed its name to Seven Stones, a move designed to reflect its diversity of …
Greater openness required by new European laws
March 31, 2005Pharmaceutical companies will be obliged to share safety data more openly from November with the adoption of new pan-European laws.The …
Europe unaffected by GSK’s manufacturing problems
March 31, 2005Sales and Marketing
Batches of GlaxoSmithKline's diabetes treatment Avandamet and depression treatment Paxil CR have been seized in the US due to continuing …
New drug applications to keep rising, European regulator says
March 31, 2005Sales and Marketing
The EMEA says it received 51 new drug applications in 2004, a figure which represents a significant rise over the …
Industry heads speak out against new European hurdle
March 31, 2005Sales and Marketing
Two leading pharmaceutical executives have criticised European regulators for demanding that new treatments be compared with existing drugs before they …
Stroke audit uncovers alarming variation in medication in UK
March 30, 2005An in-depth audit of services for stroke patients shows standards of care are generally improving – but progress is slow …
Finding the right NHS partner
March 23, 2005Pharma companies want to work with the NHS and the NHS wants to work with pharma companies. There is lots …
Latest content
FibroFind appoints Lee Borthwick as CEO
